Citations

Citations to this article as recorded by  

• Correspondence to letter to the editor on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
  Woo Hyun Paik, Heon Se Jeong, Do Hyun Park
  Clinical and Molecular Hepatology.2026; 32(2): e233.     CrossRef

Citations

Citations to this article as recorded by  

• Die primär sklerosierende Cholangitis als cholestatische Lebererkrankung und Modellerkrankung einer gestörten Darm-Leber-Achse
  Philipp Dignus, Jörg Albert, Jan G. Hengstler, Christian Trautwein
  Die Gastroenterologie.2026; 21(1): 14.     CrossRef
• Correspondence to editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
  Woo Hyun Paik, Do Hyun Park
  Clinical and Molecular Hepatology.2025; 31(2): e158.     CrossRef

Citations

Citations to this article as recorded by  

• Correspondence to editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
  Woo Hyun Paik, Do Hyun Park
  Clinical and Molecular Hepatology.2025; 31(2): e158.     CrossRef